Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.93 USD | +0.58% | +2.05% | +526.50% |
May. 24 | Landos Biopharma, Inc.(NasdaqCM:LABP) dropped from S&P TMI Index | CI |
May. 23 | AbbVie Completes Acquisition of Landos Biopharma | MT |
Evolution of the average Target Price on Landos Biopharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Landos Biopharma, Inc.
HC Wainwright | |
Jefferies & Co. | |
Raymond James | |
SVB Securities LLC | |
JPMorgan Chase | |
Craig-Hallum | |
SVB Leerink | |
JonesTrading Institutional Services | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- LABP Stock
- Consensus Landos Biopharma, Inc.